Public health in the time of bioterrorism

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1015-1018

  Perkins, Bradley A ^a   Popovic, Tanja ^a   Yeskey, Kevin ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; DECISION MAKING; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; INFECTION CONTROL; PUBLIC HEALTH SERVICE; SHORT SURVEY;

EID: 0036774150     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020444     Document Type: Short Survey

References (41)

1. Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis 2002;8:1029-34.
2. Maillard J-M, Fischer M, McKee KT Jr, Turner LF, Cline JS. First case of bioterrorism-related inhalational anthrax, Florida, 2001: North Carolina investigation. Emerg Infect Dis 2002;8:1035-8.
3. Centers for Disease Control and Prevention. Biological and chemical terrorism: Strategic plan for preparedness and response MMWR Morb Mortal Wkly Rep 2000;49:1-26.
4. Khan AS, Morse S, Lillibridge S. Public-health preparedness for biologic terrorism in the USA. Lancet 2000;356:1179-82
5. Hoffmaster AR, Meyer RF, Bowen M, Marston CK, Weyant RS, Barnett GA, et al. Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002;8:1178-82.
6. De BK, Bragg SL, Sanden GN, Wilson KE, Diem LA, Marston CK, et al. A two-component direct fluorescent-antibody assay for rapid identification of Bacillus anthracis. Emerg Infect Dis 2002;8:1060-5.
7. Hoffmaster AR, Fitzgerald CC, Ribot E, Mayer LW, Popovic T. Molecular subtyping of Bacillus anthracis and the 2001 bioterrorism-associated anthrax outbreak, United States. Emerg Infect Dis 2002;8:1111-6.
8. Mohammed MJ, Marston CK, Popovic T, Weyant RS, Tenover FC. Antimicrobial susceptibility testing of Bacillus anthracis: Comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods. J Clin Microbiol 2002;40:1902-7.
9. Quinn CP, Semenova VA, Elie CM, Romero-Steiner S, Greene C, Li H, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002;8:1103-10.
10. Thacker SB, Dannenberg AL, Hamilton DH. Epidemic intelligence service of the Centers for Disease Control and Prevention: 50 Years of training and service in applied epidemiology. Am J Epidemiol 2001;154:985-92.
11. Bales ME, Dannenberg AL, Brachman PS, Kaufmann AF, Klatsky PC, Ashford DA. Epidemiologic response to anthrax outbreaks: Field investigations, 1950-2001. Emerg Infect Dis 2002;8:1163-74.
12. Butler JC, Cohen ML, Friedman CR, Scripp RM, Watz CG. Collaboration between public health and law enforcement: New paradigms and partnerships for bioterrorism planning and response. Emerg Infect Dis 2002;8:1152-6.
13. Jernigan DB, Raghunathan PL, Bell BP, Brechner R, Bresnitz EA, Butler JC, et al. Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiologic findings. Emerg Infect Dis 2002;8:1019-28.
14. Mott JA, Treadwell TA, Hennessy TW, Rosenberg PA, Wolfe MI, Brown CM, et al. Call-tracking data and the public health response to bioterrorism-related anthrax. Emerg Infect Dis 2002;8:1088-92.
15. Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis 2001;7:933-44.
16. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-19.
17. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. MMWR Morb Mortal Wkly Rep 2001;50:941-8.
18. Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. MMWR Morb Mortal Wkly Rep 2001;50:960.
19. Centers for Disease Control and Prevention. Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. MMWR Morb Mortal Wkly Rep 2001;50:1014-1016.
20. Bell DM, Kozarsky PE, Stephens DS. Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 2002 8:222-5.
21. Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, et al. Fatal inhalational anthrax in a 94-year-old Connecticut woman. JAMA 2002;287:863-8.
22. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1008-10.
23. Polyak CS, Macy JT, Irizarry-De La Cruz M, Lai JE, McAuliffe JF, Popovic T, et al. Bioterrorism-related anthrax: International response by the Centers for Disease Control and Prevention. Emerg Infect Dis 2002;8:1056-9.
24. Tengelsen L, Hudson R, Barnes S, Hahn C. Coordinated response to possible anthrax contamination, Idaho, 2001. Emerg Infect Dis 2002;8:1093-5.
25. Centers for Disease Control and Prevention. Selected articles. Special issue. MMWR Morb Mortal Wkly Rep 2001;50:877;889-897;909-919;941-948;960;961;962;973-976;984-986; 987-990;991;1008-1010;1014-1016;1049-1051;1051-1054.
26. Perkins BA, Ashford DA. Meeting summary: Bioterrorism-related Bacillus anthracis public health research priorities. Emerg Infect Dis 2002;8:1183.
27. Centers for Disease Control and Prevention. Interim guidelines for investigation and response to Bacillus anthracis exposures. MMWR Morb Mortal Wkly Rep 2001;50:987-90.
28. Greene CM, Reefhuis J, Tan C, Fiore AE, Goldstein S, Beach MJ, et al. Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001. Emerg Infect Dis 2002;8:1048-55.
29. Sanderson WT, Hein MJ, Taylor L, Curwin BD, Kinnes GM, Seitz TA, et al. Surface sampling methods for Bacillus anthracis spore contamination. Emerg Infect Dis 2002;8:1145-51.
30. Teshale EH, Painter J, Burr GA, Mead P, Wright SV, Cseh LF, et al. Environmental sampling for spores of Bacillus anthracis. Emerg Infect Dis 2002;8:1083-7.
31. Tan CG, Sandhu HS, Crawford DC, Redd SC, Beach MJ, Buehler J, et al. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis 2002;8:1073-7.
32. Williams AA, Parashar UD, Stoica A, Ridzon R, Kirschke DL, Meyer RF, et al. Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001. Emerg Infect Dis 2002;8:1078-82.
33. Shepard CW, Soriano-Gabarro M, Zell ER, Hayslett J, Lukacs S, Goldstein S, et al. Antimicrobial postexposure prophylaxis for anthrax: Adverse events and adherence. Emerg Infect Dis 2002;8:1124-32.
34. Jefferds MD, Laserson K, Fry AM, Roy S, Hayslett J, Grummer-Strawn L, et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1138-44.
35. Williams JL, Noviello SS, Griffith KS, Wurtzel H, Hamborsky J, Perz JF, et al. Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis 2002;8:1133-7.
36. Brachman PS, Plotkin SA, Bumford FH, Atchison MM. An epidemic of inhalation anthrax: The first in the twentieth century. Am J Hyg 1960;72:6-23
37. Hsu VP, Lukacs SL, Handzel T, Hayslett J, Harper S, Hales T, et al. Opening a Bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: The public health response. Emerg Infect Dis 2002;8:1039-43.
38. Dull PM, Wilson KE, Kournikakis B, Whitney EAS, Boulet CA, Ho JYW, et al. Bacillus anthracis aerosolization associated with a contaminated mail sorting machine. Emerg Infect Dis 2002;8:1044-7.
39. Kournakakis B., Armour SJ, Boulet CA, Spence M, Barsons B. Risk Assessment of Anthrax Threat Letters. DRES Technical Report TR 2001-048. September, 2001.
40. Dewan PK, Fry AM, Laserson K, Tierney BC, Quinn CP, Hayslett JA, et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis 2002;8:1066-72.
41. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: Clinicians and public health agencies as essential partners. JAMA 2002;287:898-900.